Evidence map›Paper›PMID 37837439›Full record

ArticleDialogues in clinical neuroscience2023

An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study.

Louise Carton, Axel Bastien, Nathalie Chérot, Clément Caron, Sylvie Deheul, Olivier Cottencin, Sophie Gautier, Sophie Moreau-Crépeaux, Thibaut Dondaine, Régis Bordet

Abstract read
In one paragraph

Article in Dialogues in clinical neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. [Nitrous oxide as a party drug].Die Anaesthesiologie · 2024
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Louise CartonPharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.ORCID 0000-0002-1523-7372
Axel BastienDepartment of Psychiatry and Addiction Medicine, CHU Lille, Lille, France.
Nathalie ChérotDepartment of Occupational Health, Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR 4483, IMP ECS - IMPact de l'Environnement Chimique sur la Santé humaine, Lille, France.
Clément CaronPharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.
Sylvie DeheulPharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.
Olivier CottencinDepartment of Psychiatry and Addiction Medicine, Univ Lille, CHU Lille, INSERM U-1172, Plasticity & SubjectivitY (P SY) team, Lille Neuroscience & Cognition Centre (LiNC), Lille, France.
Sophie GautierPharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.
Sophie Moreau-CrépeauxUniv. Lille, University Student Health Services, Lille, France.
Thibaut DondainePharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.
Régis BordetPharmacology Department, Pharmacovigilance and Addictovigilance center, Univ. Lille, Inserm, CHU Lille, Lille Neuroscience and Cognition, Degenerative and Vascular Cognitive Disorders, UMR-S1172, Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesStudents represent a population at risk for substance abuse. That risk may have been exacerbated by the COVID-19 pandemic. We aimed to describe substance abuse among students and to compare consumption according to the university field.

methodsA self-administered questionnaire was sent by email to all students at the University of Lille, France, between March and July 2021. This anonymous questionnaire included questions about sociodemographic characteristics, university courses and the use of psychoactive substances (frequency, reasons, routes of administration) since the first university year.

resultsAmong the 4431 students who responded (response rate 6.1%), eighty percent declared having used alcohol since the first university year, 34% cannabis, 15.4% benzodiazepines, 14.7% opioid drugs, 7.5% cocaine, 6.8% nitrous oxide and 6.5% MDMA. More than 20% of the users of cannabis, benzodiazepines, amphetamines and cocaine reported having already felt dependent. Recreational use was described by more than 10% of benzodiazepine or opioid drug users. Nitrous oxide use was significantly more frequent in the health and sport field (

conclusionPrevention measures focusing on alcohol, cannabis, illicit psychostimulants, nitrous oxide and prescription drugs are required in the student population.

Indexed as

CannabisCocaineCOVID-19HallucinogensN-Methyl-3,4-methylenedioxyamphetamineSubstance-Related DisordersAnalgesics, OpioidBenzodiazepinesHumansNitrous OxidePandemicsStudentsAnalgesics, OpioidBenzodiazepinesCocaineHallucinogensNitrous OxideN-Methyl-3,4-methylenedioxyamphetamineAbusepsychoactive substance consumptionuniversity students

Identifiers

PMID37837439
PMCPMC10578082

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.